Equities research analysts expect that HB Fuller Co (NYSE:FUL) will announce $745.95 million in sales for the current fiscal quarter, according to Zacks. Five analysts have issued estimates for HB Fuller’s earnings, with estimates ranging from $734.00 million to $761.60 million. HB Fuller posted sales of $768.43 million during the same quarter last year, which suggests a negative year-over-year growth rate of 2.9%. The business is scheduled to issue its next quarterly earnings results on Wednesday, January 15th.
According to Zacks, analysts expect that HB Fuller will report full-year sales of $2.90 billion for the current financial year, with estimates ranging from $2.89 billion to $2.92 billion. For the next fiscal year, analysts expect that the business will report sales of $2.97 billion, with estimates ranging from $2.91 billion to $3.07 billion. Zacks’ sales calculations are an average based on a survey of research analysts that that provide coverage for HB Fuller.
HB Fuller (NYSE:FUL) last announced its quarterly earnings results on Wednesday, September 25th. The specialty chemicals company reported $0.86 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.90 by ($0.04). HB Fuller had a net margin of 4.78% and a return on equity of 13.20%. The business had revenue of $725.38 million for the quarter, compared to analysts’ expectations of $749.18 million. During the same quarter in the prior year, the firm earned $0.86 EPS. The firm’s revenue for the quarter was down 5.8% on a year-over-year basis.
A number of research firms have weighed in on FUL. Deutsche Bank set a $50.00 target price on HB Fuller and gave the stock a “hold” rating in a report on Friday, September 27th. G.Research reiterated a “buy” rating on shares of HB Fuller in a report on Tuesday, October 8th. Citigroup downgraded HB Fuller from a “neutral” rating to a “sell” rating and reduced their target price for the stock from $48.00 to $41.00 in a report on Friday, September 27th. Buckingham Research set a $60.00 target price on HB Fuller and gave the stock a “buy” rating in a report on Thursday, September 26th. Finally, JPMorgan Chase & Co. reduced their target price on HB Fuller from $51.00 to $46.00 and set a “neutral” rating on the stock in a report on Friday, June 28th. Two analysts have rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $51.80.
Shares of FUL stock traded down $0.13 during midday trading on Friday, reaching $47.69. 175,203 shares of the stock were exchanged, compared to its average volume of 468,888. HB Fuller has a 1 year low of $39.22 and a 1 year high of $51.97. The company’s 50 day moving average is $46.08 and its two-hundred day moving average is $45.94. The company has a current ratio of 2.36, a quick ratio of 1.55 and a debt-to-equity ratio of 1.77. The firm has a market cap of $2.43 billion, a PE ratio of 15.90, a price-to-earnings-growth ratio of 1.55 and a beta of 1.57.
The company also recently announced a quarterly dividend, which will be paid on Thursday, October 31st. Shareholders of record on Thursday, October 17th will be issued a dividend of $0.16 per share. The ex-dividend date of this dividend is Wednesday, October 16th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 1.34%. HB Fuller’s dividend payout ratio (DPR) is 21.33%.
In related news, CEO James Owens sold 33,275 shares of the company’s stock in a transaction that occurred on Friday, October 4th. The stock was sold at an average price of $46.34, for a total value of $1,541,963.50. Following the sale, the chief executive officer now owns 219,673 shares in the company, valued at approximately $10,179,646.82. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP Timothy J. Keenan sold 7,500 shares of the company’s stock in a transaction that occurred on Friday, July 26th. The stock was sold at an average price of $48.82, for a total value of $366,150.00. Following the completion of the sale, the vice president now owns 27,742 shares in the company, valued at approximately $1,354,364.44. The disclosure for this sale can be found here. Insiders have sold a total of 44,422 shares of company stock worth $2,077,590 in the last quarter. Company insiders own 3.46% of the company’s stock.
Hedge funds have recently added to or reduced their stakes in the stock. Harel Insurance Investments & Financial Services Ltd. bought a new position in HB Fuller in the 2nd quarter valued at approximately $46,000. Stonebridge Capital Advisors LLC bought a new position in shares of HB Fuller during the 2nd quarter valued at $60,000. Russell Investments Group Ltd. bought a new position in shares of HB Fuller during the 2nd quarter valued at $144,000. Whittier Trust Co. of Nevada Inc. lifted its holdings in shares of HB Fuller by 12.6% during the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 4,031 shares of the specialty chemicals company’s stock valued at $187,000 after buying an additional 452 shares during the period. Finally, Zions Bancorporation N.A. lifted its holdings in shares of HB Fuller by 6.0% during the 2nd quarter. Zions Bancorporation N.A. now owns 4,085 shares of the specialty chemicals company’s stock valued at $190,000 after buying an additional 232 shares during the period. 97.44% of the stock is currently owned by institutional investors and hedge funds.
About HB Fuller
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, and other specialty chemical products worldwide. The company operates through five segments: Americas Adhesives, EIMEA, Asia Pacific, Construction Adhesives, and Engineering Adhesives.
Featured Story: What is a put option?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.